University of Brawijaya Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2014
NCT01999686
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Brawijaya, Dr. Saiful Anwar Hospital, Malang, Indonesia. | Universitas Brawijaya | University of Brawijaya

Active Ingredients

Drugs in Phase 4 Trials (1)

colchicine (colbenemid) (1 trial)

Drugs in Phase 3 Trials (2)

dlbs3233 (1 trial)

sitagliptin (januvia) (1 trial)

Drugs in Phase 2 Trials (1)

beta-glucans (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Insulin Resistance (Phase 3)

Polycystic Ovary Syndrome (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4